Special Bulletin: FDA Reissues Respirators EUAs with New Decontamination-for-Reuse Instructions

June 8, 2020

Updated policy clarifies that agency is only authorizing decontamination systems’ emergency use for non-cellulose-compatible N95 respirators

The Food and Drug Administration June 7 reissued emergency use authorizations that revise policy on the types of respirators that can be decontaminated for reuse.

Citing a response to public health concerns, FDA determined that certain respirators should not be decontaminated for reuse by health care professionals during the COVID-19 public health emergency. The agency says it no longer finds it safe to recommend the decontamination and reuse of Chinese-manufactured respirators due to the possibility of varying design-and-performance results. Additionally, respirators that have exhalation valves are no longer recommended for decontamination and reuse.

Moving forward, FDA is only authorizing decontamination systems’ use on non-cellulose-compatible N95 respirators. Health care personnel should not reuse respirators that are incompatible with authorized decontamination systems but have nonetheless been decontaminated.

In all instances, health care personnel should continue to utilize the decontamination process only when new, FDA-cleared N95 respirators, NIOSH-approved N95 respirators, or other FDA-authorized respirators are not available.

FDA tomorrow at noon ET will host a webinar on respirators for health care personnel use during the COVID-19 pandemic. Learn more.

If you have questions about this policy change, contact AHA’s Mark Howell at mhowell@aha.org.

Related Resources

Other Resources
Photo credit: @UNMC_ID It’s too soon now to know what kind of impact living through the COVID-19 pandemic will have on children. But the dedication and…
Other Resources
Photo credit: @ButlerHospital Butler Hospital in Providence, Rhode Island, is sharing words of encouragement and ideas for coping with the mental health…
The Department of Health and Human Services (HHS) Sept. 16 released the federal government’s initial strategy for COVID-19 vaccine distribution, entitled The…
Special Bulletin
Special 75-minute call begins at 1 p.m. ET The AHA is hosting calls for all hospital and health system leaders to provide the latest information on and answer…
Nearly 30 representatives encourage House leaders to modify in the next COVID-19 response package impending thresholds for qualifying participants in Advanced…
AHA Center for Health Innovation Market Scan
Strategy and innovation leaders from hospitals and health systems across the country recently came together to share lessons learned and plans for the…